Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells

References

• Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011; 480:379-82; PMID:22056990; http://dx.doi.org/10.1038/nature10623
   PubMed Web of Science ®Google Scholar
• Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474:658-61; PMID:21720370; http://dx.doi.org/10.1038/nature10195
   PubMed Web of Science ®Google Scholar
• Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Ségéral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474:654-7; PMID:21613998; http://dx.doi.org/10.1038/nature10117
   PubMed Web of Science ®Google Scholar
• Powell RD, Holland PJ, Hollis T, Perrino FW. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem 2011; 286:43596-600; PMID:22069334; http://dx.doi.org/10.1074/jbc.C111.317628
   PubMed Web of Science ®Google Scholar
• Franzolin E, Pontarin G, Rampazzo C, Miazzi C, Ferraro P, Palumbo E, Reichard P, Bianchi V. The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci U S A 2013; 110:14272-7; PMID:23858451; http://dx.doi.org/10.1073/pnas.1312033110
   PubMed Web of Science ®Google Scholar
• Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T, et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med 2012; 18:1682-7; PMID:22972397; http://dx.doi.org/10.1038/nm.2964
   PubMed Web of Science ®Google Scholar
• Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012; 13:223-8; PMID:22327569; http://dx.doi.org/10.1038/ni.2236
   PubMed Web of Science ®Google Scholar
• St Gelais C, de Silva S, Amie SM, Coleman CM, Hoy H, Hollenbaugh JA, Kim B, Wu L. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons. Retrovirology 2012; 9:105; PMID:23231760; http://dx.doi.org/10.1186/1742-4690-9-105
   PubMed Web of Science ®Google Scholar
• Antonucci JM, St. Gelais C, de Silva S, Yount JS, Tang C, Ji X, Shepard C, Xiong Y, Kim B, Wu L. SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity. Nat Med 2016; 22:1072-4; PMID:27711056; http://dx.doi.org/10.1038/nm.4163
   PubMed Web of Science ®Google Scholar
• Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009; 41:829-32; PMID:19525956; http://dx.doi.org/10.1038/ng.373
   PubMed Web of Science ®Google Scholar
• Leshinsky-Silver E, Malinger G, Ben-Sira L, Kidron D, Cohen S, Inbar S, Bezaleli T, Levine A, Vinkler C, Lev D, et al. A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi-Goutieres syndrome associated with mtDNA deletions. Eur J Hum Genet 2011; 19:287-92; PMID:21102625; http://dx.doi.org/10.1038/ejhg.2010.213
   PubMed Web of Science ®Google Scholar
• Kohnken R, Kodigepalli KM, Wu L. Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications. Mol Cancer 2015; 14:176; PMID:26416562; http://dx.doi.org/10.1186/s12943-015-0446-6
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321:1807-12; PMID:18772396; http://dx.doi.org/10.1126/science.1164382
   PubMed Web of Science ®Google Scholar
• Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330-7; PMID:22810696; http://dx.doi.org/10.1038/nature11252
   PubMed Web of Science ®Google Scholar
• Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314:268-74; PMID:16959974; http://dx.doi.org/10.1126/science.1133427
   PubMed Web of Science ®Google Scholar
• Rentoft M, Lindell K, Tran P, Chabes AL, Buckland RJ, Watt DL, Marjavaara L, Nilsson AK, Melin B, Trygg J, et al. Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance. Proc Natl Acad Sci U S A 2016; 113:4723-8; PMID:27071091; http://dx.doi.org/10.1073/pnas.1519128113
   PubMed Web of Science ®Google Scholar
• Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM, Gnad F, Guan Y, Gilbert HN, Stinson J, et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 2012; 22:2315-27; PMID:23033341; http://dx.doi.org/10.1101/gr.140988.112
   PubMed Web of Science ®Google Scholar
• Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801-6; PMID:18772397; http://dx.doi.org/10.1126/science.1164368
   PubMed Web of Science ®Google Scholar
• Clifford R, Louis T, Robbe P, Ackroyd S, Burns A, Timbs AT, Wright Colopy G, Dreau H, Sigaux F, Judde JG, et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 2014; 123:1021-31; PMID:24335234; http://dx.doi.org/10.1182/blood-2013-04-490847
   PubMed Web of Science ®Google Scholar
• Schuh A, Becq J, Humphray S, Alexa A, Burns A, Clifford R, Feller SM, Grocock R, Henderson S, Khrebtukova I, et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 2012; 120:4191-6; PMID:22915640; http://dx.doi.org/10.1182/blood-2012-05-433540
   PubMed Web of Science ®Google Scholar
• Walker BA, Wardell CP, Melchor L, Hulkki S, Potter NE, Johnson DC, Fenwick K, Kozarewa I, Gonzalez D, Lord CJ, et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood 2012; 120:1077-86; PMID:22573403; http://dx.doi.org/10.1182/blood-2012-03-412981
   PubMed Web of Science ®Google Scholar
• Wang JL, Lu FZ, Shen XY, Wu Y, Zhao LT. SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation. Biochem Biophys Res Commun 2014; 455:229-33; PMID:25449277; http://dx.doi.org/10.1016/j.bbrc.2014.10.153
   PubMed Web of Science ®Google Scholar
• Bonifati S, Daly MB, St Gelais C, Kim SH, Hollenbaugh JA, Shepard C, Kennedy EM, Kim DH, Schinazi RF, Kim B, et al. SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells. Virology 2016; 495:92-100; PMID:27183329; http://dx.doi.org/10.1016/j.virol.2016.05.002
   PubMed Web of Science ®Google Scholar
• Scarisbrick JJ. Staging and management of cutaneous T-cell lymphoma. Clin Exp Dermatol 2006; 31:181-6; PMID:16487086; http://dx.doi.org/10.1111/j.1365-2230.2005.02019.x
   PubMed Web of Science ®Google Scholar
• Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713-22; PMID:17540844; http://dx.doi.org/10.1182/blood-2007-03-055749
   PubMed Web of Science ®Google Scholar
• Wong HK, Mishra A, Hake T, Porcu P. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol 2011; 155:150-66; PMID:21883142; http://dx.doi.org/10.1111/j.1365-2141.2011.08852.x
   PubMed Web of Science ®Google Scholar
• Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 2000; 18:2908-25; PMID:10920140
   PubMed Web of Science ®Google Scholar
• Contassot E, French LE. Targeting apoptosis defects in cutaneous T-cell lymphoma. J Investigat Dermatol 2009; 129:1059-61; PMID:19369931; http://dx.doi.org/10.1038/jid.2009.14
   PubMed Web of Science ®Google Scholar
• Meech SJ, Edelson R, Walsh P, Norris DA, Duke RC. Reversible resistance to apoptosis in cutaneous T cell lymphoma. Ann N Y Acad Sci 2001; 941:46-58; PMID:11594582; http://dx.doi.org/10.1111/j.1749-6632.2001.tb03710.x
   PubMed Web of Science ®Google Scholar
• Braun FK, Fecker LF, Schwarz C, Walden P, Assaf C, Durkop H, Sterry W, Eberle J. Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells. J Investigat Dermatol 2007; 127:2425-37; PMID:17495957; http://dx.doi.org/10.1038/sj.jid.5700868
   PubMed Web of Science ®Google Scholar
• Kacinski BM, Flick M. Apoptosis and cutaneous T cell lymphoma. Ann N Y Acad Sci 2001; 941:194-9; PMID:11594573; http://dx.doi.org/10.1111/j.1749-6632.2001.tb03723.x
   PubMed Web of Science ®Google Scholar
• Contassot E, Kerl K, Roques S, Shane R, Gaide O, Dupuis M, Rook AH, French LE. Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression. Blood 2008; 111:4780-7; PMID:18314443; http://dx.doi.org/10.1182/blood-2007-08-109074
   PubMed Web of Science ®Google Scholar
• Esmailzadeh S, Huang Y, Su MW, Zhou Y, Jiang X. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma. Leukemia 2015; 29:1402-13; PMID:25578476; http://dx.doi.org/10.1038/leu.2015.9
   PubMed Web of Science ®Google Scholar
• Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25:4798-811; PMID:16892092; http://dx.doi.org/10.1038/sj.onc.1209608
   PubMed Web of Science ®Google Scholar
• Safa AR, Day TW, Wu CH. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets 2008; 8:37-46; PMID:18288942; http://dx.doi.org/10.2174/156800908783497087
   PubMed Web of Science ®Google Scholar
• Safa AR, Pollok KE. Targeting the anti-apoptotic protein c-FLIP for cancer therapy. Cancers (Basel) 2011; 3:1639-71; PMID:22348197; http://dx.doi.org/10.3390/cancers3021639
   PubMedGoogle Scholar
• Safa AR. c-FLIP, a master anti-apoptotic regulator. Exp Oncol 2012; 34:176-84; PMID:23070002
   PubMedGoogle Scholar
• Villa-Morales M, Fernández-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16:85-101; PMID:22239437; http://dx.doi.org/10.1517/14728222.2011.628937
   PubMed Web of Science ®Google Scholar
• Wang Y, Su M, Zhou LL, Tu P, Zhang X, Jiang X, Zhou Y. Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription. Blood 2011; 117:3826-35; PMID:21270445; http://dx.doi.org/10.1182/blood-2010-07-294819
   PubMed Web of Science ®Google Scholar
• Wu J, Nihal M, Siddiqui J, Vonderheid EC, Wood GS. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation. J Investigat Dermatol 2009; 129:1165-73; PMID:18923451; http://dx.doi.org/10.1038/jid.2008.309
   PubMed Web of Science ®Google Scholar
• Zhang CL, Kamarashev J, Qin JZ, Burg G, Dummer R, Dobbeling U. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol 2003; 200:249-54; PMID:12754746; http://dx.doi.org/10.1002/path.1341
   PubMed Web of Science ®Google Scholar
• Nevala H, Karenko L, Vakeva L, Ranki A. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. Brit J Dermatol 2001; 145:928-37; PMID:11899146; http://dx.doi.org/10.1046/j.1365-2133.2001.04523.x
   PubMed Web of Science ®Google Scholar
• Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, Bjornson RD, Maman Y, Wang T, Tordoff J, et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet 2015; 47:1011-9; PMID:26192916; http://dx.doi.org/10.1038/ng.3356
   PubMed Web of Science ®Google Scholar
• da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, Vermeer MH, Rabadan R, Ferrando A, Palomero T. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. Nat Genet 2015; 47:1465-70; PMID:26551667; http://dx.doi.org/10.1038/ng.3442
   PubMed Web of Science ®Google Scholar
• McGirt LY, Jia P, Baerenwald DA, Duszynski RJ, Dahlman KB, Zic JA, Zwerner JP, Hucks D, Dave U, Zhao Z, et al. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood 2015; 126:508-19; PMID:26082451; http://dx.doi.org/10.1182/blood-2014-11-611194
   PubMed Web of Science ®Google Scholar
• Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, Xi L, Meng Q, Langridge T, Drummond J, et al. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet 2015; 47:1426-34; PMID:26551670; http://dx.doi.org/10.1038/ng.3444
   PubMed Web of Science ®Google Scholar
• Kiel MJ, Sahasrabuddhe AA, Rolland DC, Velusamy T, Chung F, Schaller M, Bailey NG, Betz BL, Miranda RN, Porcu P, et al. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome. Nat Commun 2015; 6:8470; PMID:26415585; http://dx.doi.org/10.1038/ncomms9470
   PubMed Web of Science ®Google Scholar
• Ungewickell A, Bhaduri A, Rios E, Reuter J, Lee CS, Mah A, Zehnder A, Ohgami R, Kulkarni S, Armstrong R, et al. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2. Nat Genet 2015; 47:1056-60; PMID:26258847; http://dx.doi.org/10.1038/ng.3370
   PubMed Web of Science ®Google Scholar
• de Silva S, Wang F, Hake TS, Porcu P, Wong HK, Wu L. Downregulation of SAMHD1 expression correlates with promoter DNA methylation in Sezary syndrome patients. J Investigat Dermatol 2014; 134:562-5; PMID:23884314; http://dx.doi.org/10.1038/jid.2013.311
   PubMed Web of Science ®Google Scholar
• de Silva S, Hoy H, Hake TS, Wong HK, Porcu P, Wu L. Promoter methylation regulates SAMHD1 gene expression in human CD4+ T cells. J Biol Chem 2013; 288:9284-92; PMID:23426363; http://dx.doi.org/10.1074/jbc.M112.447201
   PubMed Web of Science ®Google Scholar
• Cribier A, Descours B, Valadao AL, Laguette N, Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep 2013; 3:1036-43; PMID:23602554; http://dx.doi.org/10.1016/j.celrep.2013.03.017
   PubMed Web of Science ®Google Scholar
• Pauls E, Ruiz A, Badia R, Permanyer M, Gubern A, Riveira-Munoz E, Torres-Torronteras J, Alvarez M, Mothe B, Brander C, et al. Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells. J Immunol 2014; 193:1988-97; PMID:25015816; http://dx.doi.org/10.4049/jimmunol.1400873
   PubMed Web of Science ®Google Scholar
• St Gelais C, de Silva S, Hach JC, White TE, Diaz-Griffero F, Yount JS, Wu L. Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1. J Virol 2014; 88:5834-44; PMID:24623419; http://dx.doi.org/10.1128/JVI.00155-14
   PubMed Web of Science ®Google Scholar
• Kajstura M, Halicka HD, Pryjma J, Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “sub-G1” peaks on DNA content histograms. Cytometry Part A: J Int Soc Anal Cytol 2007; 71:125-31; PMID:17252584; http://dx.doi.org/10.1002/cyto.a.20357
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53:3976-85; PMID:8358726
   PubMed Web of Science ®Google Scholar
• Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989; 49:5870-8; PMID:2790800
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim YY, Ju JW, Han BG, Park SI, Park BJ. Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. Biochem Biophys Res Commun 2001; 289:1205-10; PMID:11741321; http://dx.doi.org/10.1006/bbrc.2001.6086
   PubMed Web of Science ®Google Scholar
• Behrendt R, Schumann T, Gerbaulet A, Nguyen LA, Schubert N, Alexopoulou D, Berka U, Lienenklaus S, Peschke K, Gibbert K, et al. Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Rep 2013; 4:689-96; PMID:23972988; http://dx.doi.org/10.1016/j.celrep.2013.07.037
   PubMed Web of Science ®Google Scholar
• Rehwinkel J, Maelfait J, Bridgeman A, Rigby R, Hayward B, Liberatore RA, Bieniasz PD, Towers GJ, Moita LF, Crow YJ, et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J 2013; 32:2454-62; PMID:23872947; http://dx.doi.org/10.1038/emboj.2013.163
   PubMed Web of Science ®Google Scholar
• Sze A, Belgnaoui SM, Olagnier D, Lin R, Hiscott J, van Grevenynghe J. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe 2013; 14:422-34; PMID:24139400; http://dx.doi.org/10.1016/j.chom.2013.09.009
   PubMed Web of Science ®Google Scholar
• Chang DW, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S, Peter ME, Yang X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 2002; 21:3704-14; PMID:12110583; http://dx.doi.org/10.1093/emboj/cdf356
   PubMed Web of Science ®Google Scholar
• Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW, Briand C, Grutter MG. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 2002; 277:45162-71; PMID:12215447; http://dx.doi.org/10.1074/jbc.M206882200
   PubMed Web of Science ®Google Scholar
• Pop C, Oberst A, Drag M, Van Raam BJ, Riedl SJ, Green DR, Salvesen GS. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J 2011; 433:447-57; PMID:21235526; http://dx.doi.org/10.1042/BJ20101738
   PubMed Web of Science ®Google Scholar
• Dummer R, Michie SA, Kell D, Gould JW, Haeffner AC, Smoller BR, Warnke RA, Wood GS. Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutaneous Pathol 1995; 22:11-7; PMID:7751472; http://dx.doi.org/10.1111/j.1600-0560.1995.tb00733.x
   PubMed Web of Science ®Google Scholar
• Wang F, St Gelais C, de Silva S, Zhang H, Geng Y, Shepard C, Kim B, Yount JS, Wu L. Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection. Virology 2016; 487:273-84; PMID:26580513; http://dx.doi.org/10.1016/j.virol.2015.10.024
   PubMed Web of Science ®Google Scholar